Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.

Journal article

Sammons EL. et al, (2024), Ophthalmology

Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus.

Journal article

Chew Sue Mei S. et al, (2024), Endocrinology, diabetes & metabolism case reports, 2024, 23 - 133

Live to eat and eat to live longer.

Journal article

Adler A. and Saksena R., (2023), Nat Food

Teplizumab approval for type 1 diabetes in the USA.

Journal article

Beran D. et al, (2023), Lancet Diabetes Endocrinol, 11, 78 - 80

Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.

Journal article

Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842

Endpoints and estimands: understanding trials of weight-loss drugs.

Journal article

Adler AI., (2022), Nat Med, 28, 2005 - 2006

How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?

Journal article

Cowie MR. et al, (2022), International journal of cardiology, 365, 61 - 68

Glucocorticoid-induced hyperglycaemia and diabetes: Call for action.

Journal article

Golubic R. et al, (2022), Diabet Med, 39

Insulin resistance and incident heart failure: a meta-analysis.

Journal article

Erqou S. et al, (2022), European journal of heart failure

Nintedanib for treating progressive fibrosing interstitial lung diseases.

Journal article

Adler AI. et al, (2021), Lancet Respir Med

Load More